Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder

IF 3 Q2 SUBSTANCE ABUSE Alcohol (Hanover, York County, Pa.) Pub Date : 2024-05-08 DOI:10.1111/acer.15345
Paola Zuluaga, Daniel Fuster, Rafael Blanes, Anna Hernández-Rubio, Laia Miquel, Marta Torrens, Gabriel Rubio, Ferrán Bolao, Suthat Liangpunsakul, Enric Abellí-Deulofeu, Fernando Rodriguez de Fonseca, Robert Muga, CohRTA
{"title":"Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder","authors":"Paola Zuluaga,&nbsp;Daniel Fuster,&nbsp;Rafael Blanes,&nbsp;Anna Hernández-Rubio,&nbsp;Laia Miquel,&nbsp;Marta Torrens,&nbsp;Gabriel Rubio,&nbsp;Ferrán Bolao,&nbsp;Suthat Liangpunsakul,&nbsp;Enric Abellí-Deulofeu,&nbsp;Fernando Rodriguez de Fonseca,&nbsp;Robert Muga,&nbsp;CohRTA","doi":"10.1111/acer.15345","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Effective screening for alcohol-associated liver disease is relevant in the context of chronic, excessive alcohol consumption. Patients with alcohol-associated liver disease are often not diagnosed until their liver disease is decompensated. We analyzed the prevalence and associations of Fibrosis-4 index (FIB-4) values suggestive of advanced liver fibrosis in patients referred for their first treatment of alcohol use disorder (AUD).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a cross-sectional, multicenter study of noncirrhotic individuals referred for their first AUD treatment between March 2013 and April 2021. We obtained sociodemographic data, substance use characteristics, and blood samples at admission. We considered a FIB-4 value ≥2.67 suggestive of advanced liver fibrosis and used logistic regression analyses to identify features associated with this value.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We included 604 patients (67% male), with a median age at admission of 48 years [IQR: 41–56 years]. The median duration of regular alcohol consumption was 21 years [IQR: 18–30 years] and the median alcohol consumption was 105 standard drink units (SDU)/week [IQR: 63–160 SDU/week]. A FIB-4 value ≥ 2.67 was present in 19.3% of cases. These patients reported more frequent binge drinking (75.4% vs. 66%, <i>p</i> = 0.05) than those with FIB-4 values below 2.67. In multivariate analysis, a history of binge drinking (OR 1.9, 95% CI, 1.05–3.47), anemia (OR 2.95, 95% CI, 1.42–6.11), leukopenia (OR 7.46, 95% CI, 2.07–26.8), and total serum bilirubin &gt;1 mg/dL (OR 6.46, 95% CI, 3.57–11.7) were independently associated with FIB-4 values ≥2.67.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>One in five patients admitted to treatment for AUD without evidence of decompensated liver disease have FIB-4 values suggestive of advanced liver fibrosis. The presence of a binge drinking history, anemia, leukopenia, and elevated bilirubin levels is associated with high FIB-4 values.</p>\n </section>\n </div>","PeriodicalId":72145,"journal":{"name":"Alcohol (Hanover, York County, Pa.)","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acer.15345","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcohol (Hanover, York County, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/acer.15345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Effective screening for alcohol-associated liver disease is relevant in the context of chronic, excessive alcohol consumption. Patients with alcohol-associated liver disease are often not diagnosed until their liver disease is decompensated. We analyzed the prevalence and associations of Fibrosis-4 index (FIB-4) values suggestive of advanced liver fibrosis in patients referred for their first treatment of alcohol use disorder (AUD).

Methods

We conducted a cross-sectional, multicenter study of noncirrhotic individuals referred for their first AUD treatment between March 2013 and April 2021. We obtained sociodemographic data, substance use characteristics, and blood samples at admission. We considered a FIB-4 value ≥2.67 suggestive of advanced liver fibrosis and used logistic regression analyses to identify features associated with this value.

Results

We included 604 patients (67% male), with a median age at admission of 48 years [IQR: 41–56 years]. The median duration of regular alcohol consumption was 21 years [IQR: 18–30 years] and the median alcohol consumption was 105 standard drink units (SDU)/week [IQR: 63–160 SDU/week]. A FIB-4 value ≥ 2.67 was present in 19.3% of cases. These patients reported more frequent binge drinking (75.4% vs. 66%, p = 0.05) than those with FIB-4 values below 2.67. In multivariate analysis, a history of binge drinking (OR 1.9, 95% CI, 1.05–3.47), anemia (OR 2.95, 95% CI, 1.42–6.11), leukopenia (OR 7.46, 95% CI, 2.07–26.8), and total serum bilirubin >1 mg/dL (OR 6.46, 95% CI, 3.57–11.7) were independently associated with FIB-4 values ≥2.67.

Conclusions

One in five patients admitted to treatment for AUD without evidence of decompensated liver disease have FIB-4 values suggestive of advanced liver fibrosis. The presence of a binge drinking history, anemia, leukopenia, and elevated bilirubin levels is associated with high FIB-4 values.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
首次接受酒精使用障碍治疗时,实验室值提示肝纤维化晚期的个体临床特征。
背景:在长期过量饮酒的情况下,有效筛查酒精相关性肝病具有重要意义。酒精相关性肝病患者往往在肝病失代偿期才被确诊。我们分析了首次治疗酒精使用障碍(AUD)的转诊患者中提示晚期肝纤维化的纤维化-4指数(FIB-4)值的患病率及其相关性:我们对2013年3月至2021年4月期间转诊接受首次AUD治疗的非肝硬化患者进行了一项横断面多中心研究。我们获得了社会人口学数据、药物使用特征和入院时的血液样本。我们认为 FIB-4 值≥2.67 提示晚期肝纤维化,并使用逻辑回归分析确定与该值相关的特征:我们共纳入了 604 名患者(67% 为男性),入院时的中位年龄为 48 岁 [IQR:41-56 岁]。定期饮酒时间的中位数为 21 年 [IQR:18-30 年],饮酒量的中位数为 105 标准饮料单位 (SDU)/周 [IQR:63-160 SDU/周]。19.3%的病例 FIB-4 值≥ 2.67。与 FIB-4 值低于 2.67 的患者相比,这些患者更频繁地暴饮暴食(75.4% 对 66%,P = 0.05)。在多变量分析中,暴饮暴食史(OR 1.9,95% CI,1.05-3.47)、贫血(OR 2.95,95% CI,1.42-6.11)、白细胞减少(OR 7.46,95% CI,2.07-26.8)和血清总胆红素>1 mg/dL(OR 6.46,95% CI,3.57-11.7)与 FIB-4 值≥2.67 独立相关:每五名接受 AUD 治疗但无肝病失代偿证据的患者中,就有一人的 FIB-4 值提示存在晚期肝纤维化。酗酒史、贫血、白细胞减少和胆红素水平升高与FIB-4值偏高有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.40
自引率
0.00%
发文量
0
期刊最新文献
Santa Claus, the Tooth Fairy, and purported lifetime nondrinkers: Ramifications for observational evidence about alcohol and health. Alcohol hangovers as a predictor of the development of immune-related chronic diseases. Impaired or not impaired: The accuracy of the Montreal Cognitive Assessment in detecting cognitive impairment among patients with alcohol use disorder. Clinical characteristics of seizure recurrence and epilepsy development in patients with alcohol-related seizures. Closing the gaps in alcohol behavior change: A real-world study of a digital intervention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1